All News

Raw Materials

Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
14 May 2024
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
Are you looking for a
Learning From Experience: Navigating Cell & Gene Therapy Development Challenges with Productive CDMO Partnerships
9 May 2024
Learning From Experience: Navigating Cell & Gene Therapy Development Challenges with Productive CDMO Partnerships
In this interview, Andy Lewin,
Maximizing cost efficiency, reducing GMP footprint, and eliminating bottlenecks in Lentiviral virus production: A Case Study with the Cytegrity™ Producer Cell Line in the scale-X™ Fixed-Bed Bioreactor.
25 March 2024
Maximizing cost efficiency, reducing GMP footprint, and eliminating bottlenecks in Lentiviral virus production: A Case Study with the Cytegrity™ Producer Cell Line in the scale-X™ Fixed-Bed Bioreactor.
Discover revolutionary advancements in LVV
Employing Innovative Approaches, Technological Advancements and Collaborative Strategies to Address Industry Challenges
29 February 2024
Employing Innovative Approaches, Technological Advancements and Collaborative Strategies to Address Industry Challenges
Sharmilee Patel, Head of Business
POPULAR NEWS ITEMS
Image
14 May 2024

Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing

Image
8 April 2024

Women in Advanced Therapies Global 2024, Virtual Event

Image
25 March 2024

RNA Connect 2025, South Carolina

Large Impact in a Small Package: Small Extracellular Vesicles as Nanotherapeutics
28 February 2024
Large Impact in a Small Package: Small Extracellular Vesicles as Nanotherapeutics
Maroun Khoury and Max Kunze,
Going Non-Viral: How Cell Therapy Manufacturing is Moving Away From Viral Vectors
26 February 2024
Going Non-Viral: How Cell Therapy Manufacturing is Moving Away From Viral Vectors
Are you interested in editing
Maximizing Cost Effectiveness and Reducing Wastage with Innovative Plasmid Solutions for Gene Therapies
29 January 2024
Maximizing Cost Effectiveness and Reducing Wastage with Innovative Plasmid Solutions for Gene Therapies
In this interview, Ramin Baghirzade,
Revolutionizing Regenerative Medicine: Exploring the Promise and Challenges of Allogeneic Therapies
28 November 2023
Revolutionizing Regenerative Medicine: Exploring the Promise and Challenges of Allogeneic Therapies
David Sourdive joins us in
Load more News
RECOMENDED TOPICS
Automation & Digitisation
Characterisation
CMC
GMP
Logistics
Partnering
Point of Care
Raw Materials
Scaling Up
Skills, Talent & Development
Supply Chain
POPULAR NEWS ITEMS
Image

Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing

Image

Women in Advanced Therapies Global 2024, Virtual Event

Image

RNA Connect 2025, South Carolina